Written procedures are not for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product.
Inspection Record
SCA Pharmaceuticals LLC — FDA 483 Findings
Inspectors Samir C Gala · Jazmine N BrownThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established and followed.
Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate design to facilitate operations for its intended use and cleaning and maintenance.
Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.
Batch production and control records do not include complete information relating to the production and control of each batch.
Your firm failed to establish written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality that they are purported or represented to possess.
There is a failure to thoroughly review any unexplained discrepancy whether or not the batch has been ah eady distributed.
About this record
Extracted automatically from the document US FDA published on 2025-01-21. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
